Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.
عرض / فتح
التاريخ
2021-10-11المؤلف
Abu-Raddad, Laith JChemaitelly, Hiam
Yassine, Hadi M
Benslimane, Fatiha M
Al Khatib, Hebah A
Tang, Patrick
Malek, Joel A
Coyle, Peter
Ayoub, Houssein H
Al Kanaani, Zaina
Al Kuwari, Einas
Jeremijenko, Andrew
Kaleeckal, Anvar Hassan
Latif, Ali Nizar
Shaik, Riyazuddin Mohammad
Abdul Rahim, Hanan F
Nasrallah, Gheyath K
Al Kuwari, Mohamed Ghaith
Al Romaihi, Hamad Eid
Al-Thani, Mohamed H
Al Khal, Abdullatif
Butt, Adeel A
Bertollini, Roberto
...show more authors ...show less authors
البيانات الوصفية
عرض كامل للتسجيلةالملخص
Strategies for rolling out vaccination against Coronavirus Disease 2019 (Covid-19) varied across countries. A key question is whether delaying administration of the second vaccine dose to vaccinate the largest number of people in the shortest time, in situations of limited vaccine supplies and high incidence, could avert more disease cases, hospitalizations and deaths than the current protocol of a second dose shortly after the first dose.
المجموعات
- العلوم الحيوية الطبية [723 items ]
- أبحاث فيروس كورونا المستجد (كوفيد-19) [832 items ]